Basolateral chloride transporters in autosomal dominant polycystic kidney disease

被引:27
|
作者
Lebeau, C
Hanaoka, K
Moore-Hoon, ML
Guggino, WB
Beauwens, R
Devuyst, O
机构
[1] Catholic Univ Louvain, Div Nephrol, B-1200 Brussels, Belgium
[2] Free Univ Brussels, Dept Phytopathol, Brussels, Belgium
[3] Johns Hopkins Univ, Sch Med, Dept Physiol, Bethesda, MD USA
[4] NIDCD, NIH, Bethesda, MD USA
来源
关键词
ADPKD; anion exchanger; CFTR; chloride channel; renal cyst; sodium-potassium-chloride cotransporter;
D O I
10.1007/s00424-002-0880-3
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Transepithelial Cl- secretion mediated by apical cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels plays a key role in cyst fluid accumulation in autosomal dominant polycystic kidney disease (ADPKD). The molecular identity of the basolateral transporter(s) responsible for Cl- entry in ADPKD cells is unknown, although pharmacological studies suggest that a bumetanide-sensitive Na+-K+-2Cl(-) cotransporter (NKCC/BSC) is involved. We investigated the expression of NKCC1, CFTR and anion exchanger type I (AE1) in ADPKD kidneys and cultured ADPKD cells. Immunoblotting and immunoprecipitation detected NKCC1 at similar to170 kDa in ADPKD cells and kidney extracts. Immunostaining located NKCC1 in one-third of ADPKD cysts, with a pattern of basolateral reactivity. Staining of serial sections showed that cysts positive for NKCC1 also stained for CFTR. Additional studies demonstrated that AE1 is expressed in ADPKD kidneys, and is located at the basolateral pole of CFTR-positive ADPKD cysts that do not express NKCC1. RT-PCR and sequence analyses confirmed the selective expression of NKCC1 or AEI in cultured ADPKD cells that also express CFTR. The fact that most CFTR-positive ADPKD cysts also express NKCC1 suggests that transepithelial Cl- secretion in ADPKD involves molecular mechanisms similar to secretory epithelia. AE1 might be an alternative basolateral pathway for Cl- in a minority of cysts.
引用
收藏
页码:722 / 731
页数:10
相关论文
共 50 条
  • [11] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Pljesa, Steva
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 340 - 347
  • [12] Autosomal Dominant Polycystic Kidney Disease
    Suarez, Maria Lourdes Gonzalez
    Titan, Silvia
    Dahl, Neera K.
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2024, 31 (06): : 496 - 503
  • [13] Autosomal Dominant Polycystic Kidney Disease
    Perumareddi, Parvathi
    Trelka, Darin P.
    PRIMARY CARE, 2020, 47 (04): : 673 - 689
  • [14] Autosomal Dominant Polycystic Kidney Disease
    Pei, York
    Watnick, Terry
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 115 - 117
  • [15] Autosomal dominant polycystic kidney disease
    Pirson, Y
    Chauveau, D
    Watson, ML
    Zeier, M
    Breuning, MH
    M S-MEDECINE SCIENCES, 1997, 13 (01): : 37 - 44
  • [16] Autosomal dominant polycystic kidney disease
    Cornec-Le Gall, Emilie
    Alam, Ahsan
    Perrone, Ronald D.
    LANCET, 2019, 393 (10174): : 919 - 935
  • [17] Autosomal dominant polycystic kidney disease
    Torres, Vicente E.
    Harris, Peter C.
    Pirson, Yves
    LANCET, 2007, 369 (9569): : 1287 - 1301
  • [18] Autosomal dominant polycystic kidney disease
    Beebe, DK
    AMERICAN FAMILY PHYSICIAN, 1996, 53 (03) : 925 - 931
  • [19] Autosomal dominant polycystic kidney disease
    Grantham, Jared J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (14): : 1477 - 1485
  • [20] Autosomal dominant polycystic kidney disease
    Torres, VE
    Harris, PC
    NEFROLOGIA, 2003, 23 : 14 - 22